Floatz logo

Tsc-201-B0702

HPV-Related Penile Squamous Cell Carcinoma

TScan Therapeutics, Inc.Cell therapyPhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the HPV-Related Penile Squamous Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Christian Hinrichs
Phase 2B
Fludarabine
Christian Hinrichs
Phase 2B
e7 tcr-t cells
Christian Hinrichs
Phase 2B
Atezolizumab
M.D. Anderson Cancer Center
Phase 2CCC
scg142
SCG Cell Therapy Pte. Ltd.
Phase 1/2CC

View all 11 →

Same molecule, other indications

Tsc-201-B0702 is also rated in:

anogenital human papillomavirus infectionDormant
CC
Indicative ·
43 / 100
View asset →
non-small cell lung carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
cervical carcinomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →